Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
1.040
-0.960 (-48.00%)
At close: Dec 20, 2024, 4:00 PM
1.020
-0.020 (-1.92%)
After-hours: Dec 20, 2024, 7:58 PM EST
Galectin Therapeutics Employees
Galectin Therapeutics had 14 employees as of December 31, 2023. The number of employees increased by 2 or 16.67% compared to the previous year.
Employees
14
Change (1Y)
2
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$3,230,714
Market Cap
65.27M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Jin Medical International | 245 |
Protalix BioTherapeutics | 208 |
Enanta Pharmaceuticals | 145 |
PepGen | 64 |
InflaRx | 62 |
Black Diamond Therapeutics | 54 |
Elutia | 54 |
Atossa Therapeutics | 12 |
GALT News
- 1 day ago - Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday? - Benzinga
- 1 day ago - Galectin Therapeutics Announces Top-Line Results of NAVIGATE Clinical Trial Evaluating Belapectin in Patients with Cirrhotic Portal Hypertension Caused by MASH - GlobeNewsWire
- 4 weeks ago - Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting - GlobeNewsWire
- 5 weeks ago - Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update - GlobeNewsWire
- 2 months ago - Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting - GlobeNewsWire
- 3 months ago - Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update - GlobeNewsWire
- 5 months ago - Galectin Therapeutics Appoints Khurram Jamil, M.D. to Chief Medical Officer - GlobeNewsWire